A. George

APP intracellular domain is increased and soluble Aβ is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease

C. Masters, K. Beyreuther, G. Evin, 2004, Neurobiology of Disease.

ATRX interacts with H 3 . 3 in maintaining telomere structural integrity in pluripotent embryonic stem cells

R. Hannan, J. Mann, K. Choo, 2010 .

A Serial Analysis of Gene Expression Profile of the Alzheimer’s Disease Tg2576 Mouse Model

T. Beißbarth, C. Masters, V. Perreau, 2010, Neurotoxicity Research.

New Roles for the Nucleolus in Health and Disease

K. Hannan, A. George, Nadine Hein, 2018, BioEssays : news and reviews in molecular, cellular and developmental biology.

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

J. Zuber, M. Dawson, R. Pearson, 2017, Blood.

MODULATION OF RNA POLYMERASE I TRANSCRIPTION IN NORMAL AND MALIGNANT HAEMATOPOIESIS

R. Hannan, K. Hannan, R. Ferreira, 2019, Experimental Hematology.

A new window on cancer therapy? Targeting the nucleolus and ribosome biogenesis using the small molecule inhibitor of polymerase I transcription, CX-5461

R. Hannan, S. Harrison, A. George, 2015 .

Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway

Cathryn M. Gould, U. Kutay, P. Madhamshettiwar, 2021, bioRxiv.

Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient

R. D'Andrea, David M. Lawrence, L. To, 2017, Haematologica.

Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells

S. Bröer, R. Hannan, A. George, 2022, Frontiers in Pharmacology.